Authors:
Lay, L
Panza, L
Poletti, L
Prosperi, D
Canevari, S
Perico, ME
Citation: L. Lay et al., Improvement of the synthesis of immunological carbohydrate vaccines containing the tumour associate antigen CaMBr1, EUR J ORG C, (22), 2001, pp. 4331-4336
Authors:
Negri, DRM
Mezzanzanica, D
Sacco, S
Gadina, M
Benigni, F
Cajola, L
Finocchiaro, G
Ghezzi, P
Canevari, S
Citation: Drm. Negri et al., Role of cytokines in cancer cachexia in a murine model of intracerebral injection of human tumours, CYTOKINE, 15(1), 2001, pp. 27-38
Authors:
Mangiarotti, F
Miotti, S
Galmozzi, E
Mazzi, M
Sforzini, S
Canevari, S
Tomassetti, A
Citation: F. Mangiarotti et al., Functional effect of point mutations in the alpha-folate receptor gene of CABA I ovarian carcinoma cells, J CELL BIOC, 81(3), 2001, pp. 488-498
Authors:
Turatti, F
Mezzanzanica, D
Nardini, E
Luison, E
Maffioli, L
Bombardieri, E
de Lalla, C
Canevari, S
Figini, M
Citation: F. Turatti et al., Production and validation of the pharmacokinetics of a single-chain Fv fragment of the MGR6 antibody for targeting of tumors expressing HER-2, CANCER IMMU, 49(12), 2001, pp. 679-686
Authors:
Galmozzi, E
Tomassetti, A
Sforzini, S
Mangiarotti, F
Mazzi, M
Nachmanoff, K
Elwood, PC
Canevari, S
Citation: E. Galmozzi et al., Exon 3 of the alpha folate receptor gene contains a 5 ' splice site which confers enhanced ovarian carcinoma specific expression, FEBS LETTER, 502(1-2), 2001, pp. 31-34
Authors:
Appierto, V
Cavadini, E
Pergolizzi, R
Cleris, L
Lotan, R
Canevari, S
Formelli, F
Citation: V. Appierto et al., Decrease in drug accumulation and in tumour aggressiveness marker expression in a fenretinide-induced resistant ovarian tumour cell line, BR J CANC, 84(11), 2001, pp. 1528-1534
Citation: S. Ferrini et al., Bispecific monoclonal antibodies for the targeting of type I ribosome-inactivating proteins against hematological malignancies, METH MOL B, 166, 2001, pp. 177-192
Authors:
Ferrari, F
Rossi, S
Bonferoni, MC
Canevari, S
Dobetti, L
Caramella, C
Citation: F. Ferrari et al., The influence of product brand and batch-to-batch variability on super-disintegrant performance, STP PHARM S, 10(6), 2000, pp. 459-465
Authors:
Bagnoli, M
Tomassetti, A
Figini, M
Flati, S
Dolo, V
Canevari, S
Miotti, S
Citation: M. Bagnoli et al., Downmodulation of caveolin-1 expression in human ovarian carcinoma is directly related to alpha-folate receptor overexpression, ONCOGENE, 19(41), 2000, pp. 4754-4763
Authors:
Perico, ME
Mezzanzanica, D
Luison, E
Alberti, P
Panza, L
Russo, G
Canevari, S
Citation: Me. Perico et al., Development of a new vaccine formulation that enhances the immunogenicity of tumor-associated antigen CaMBr1, CANCER IMMU, 49(6), 2000, pp. 296-304
Authors:
Miotti, S
Bagnoli, M
Tomassetti, A
Colnaghi, MI
Canevari, S
Citation: S. Miotti et al., Interaction of folate receptor with signaling molecules lyn and G alpha(i-3) in detergent-resistant complexes from the ovary carcinoma cell line IGROV1, J CELL SCI, 113(2), 2000, pp. 349-357
Authors:
Dosio, F
Arpicco, S
Canevari, S
Figini, M
Gastaldi, D
Citation: F. Dosio et al., Single-step purification of immunotoxins containing a high ionic charge ribosome inactivating protein clavin by carboxymethyl high-performance membrane chromatography, J CHROMAT A, 830(2), 1999, pp. 329-335
Authors:
Neglia, F
Orengo, AM
Cilli, M
Meazza, R
Tomassetti, A
Canevari, S
Melani, C
Colombo, MP
Ferrini, S
Citation: F. Neglia et al., DNA vaccination against the ovarian carcinoma-associated antigen folate receptor alpha (FR alpha) induces cytotoxic T lymphocyte and antibody responses in mice, CANC GENE T, 6(4), 1999, pp. 349-357
Authors:
Dolo, V
D'Ascenzo, S
Violini, S
Pompucci, L
Festuccia, C
Ginestra, A
Vittorelli, ML
Canevari, S
Pavan, A
Citation: V. Dolo et al., Matrix-degrading proteinases are shed in membrane vesicles by ovarian cancer cells in vivo and in vitro, CLIN EXP M, 17(2), 1999, pp. 131-140
Authors:
Canevari, S
Colombo, D
Compostella, F
Panza, L
Ronchetti, F
Russo, G
Toma, L
Citation: S. Canevari et al., Synthesis, modeling and binding affinity of an ester analogue of the terminal trisaccharide of the tumor-associated antigen globo-H-1, TETRAHEDRON, 55(5), 1999, pp. 1469-1478
Authors:
Miotti, S
Negri, DRM
Valota, O
Calabrese, M
Bolhuis, RLH
Gratama, JW
Colnaghi, MI
Canevari, S
Citation: S. Miotti et al., Level of anti-mouse-antibody response induced by bi-specific monoclonal antibody OC/TR in ovarian-carcinoma patients is associated with longer survival, INT J CANC, 84(1), 1999, pp. 62-68
Authors:
Smans, KA
Ingvarsson, MB
Lindgren, P
Canevari, S
Walt, H
Stigbrand, T
Backstrom, T
Millan, JL
Citation: Ka. Smans et al., Bispecific antibody-mediated lysis of primary cultures of ovarian carcinoma cells using multiple target antigens, INT J CANC, 83(2), 1999, pp. 270-277
Authors:
Adobati, E
Zacchetti, A
Perico, ME
Cremonesi, F
Rasi, G
Vallebona, PS
Hagenaars, M
Kuppen, PJK
Pastan, I
Panza, L
Russo, G
Colnaghi, MI
Canevari, S
Citation: E. Adobati et al., Expression profile of saccharide epitope CaMBr1 in normal and neoplastic tissue from dogs, cats, and rats: Implication for the development of human-derived cancer vaccines, HISTOCHEM J, 31(11), 1999, pp. 729-737
Authors:
Mezzanzanica, D
Canevari, S
Mazzoni, A
Figini, M
Colnaghi, MI
Waks, T
Schindler, DG
Eshhar, Z
Citation: D. Mezzanzanica et al., Transfer of chimeric receptor gene made of variable regions of tumor-specific antibody confers anticarbohydrate specificity on T cells, CANC GENE T, 5(6), 1998, pp. 401-407
Authors:
Rodolfo, M
Melani, C
Zilocchi, C
Cappetti, B
Luison, E
Arioli, I
Parenza, M
Canevari, S
Colombo, MP
Citation: M. Rodolfo et al., IgG2a induced by interleukin (IL) 12-producing tumor cell vaccines but notIgG1 induced by IL-4 vaccine is associated with the eradication of experimental metastases, CANCER RES, 58(24), 1998, pp. 5812-5817